Tag: <span>Pulmonary</span>

Home / Pulmonary
NASA Technologies that Can Improve Healthcare and Fitness
Post

NASA Technologies that Can Improve Healthcare and Fitness

For NASA, making sure astronauts are healthy while they’re away from our home planet is a top priority. From experiments on the International Space Station to aeronautics research, NASA programs are developing new technologies that can improve fitness, treat disease, and save lives. From pocket-sized labs to next-level stethoscopes, here are a few examples of...

COVID-19 causes pulmonary arterial thrombosis and damages other organs as well as the lungs
Post

COVID-19 causes pulmonary arterial thrombosis and damages other organs as well as the lungs

by Mag. Johannes Angerer, Medical University of Vienna COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas. These are the findings of a first major series of autopsies in Austria, conducted as part...

Pulmonary rehab associated with lower COPD mortality
Post

Pulmonary rehab associated with lower COPD mortality

(HealthDay)—Initiation of pulmonary rehabilitation within three months of hospital discharge for chronic obstructive pulmonary disease (COPD) is significantly associated with a lower risk for mortality at one year for Medicare beneficiaries, according to a study published in the May 12 issue of the Journal of the American Medical Association. Peter K. Lindenauer, M.D., from the...

How blocking iron drives the lung immune system to control infection
Post

How blocking iron drives the lung immune system to control infection

by Ciara O’shea, Trinity College Dublin Although COVID-19 commands the headlines today, tuberculosis (TB) remains the biggest infection killer in the world and multiple drug resistant TB, which does not respond to regular antibiotics, continues to be a major threat to global health. TB is caused by bacteria (Mycobacterium tuberculosis) that most often affect the...

Mucus breakthrough could help patients breathe easy
Post

Mucus breakthrough could help patients breathe easy

A discovery about how mucus thickness is regulated could help to improve airway-clearing treatment options for people with chronic respiratory conditions such as asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD) At a glance Researchers have discovered the reason why the excessive amounts of mucus produced by patients with respiratory illnesses is thicker than...

Post

Researchers identify key mechanisms involved in pulmonary fibrosis development

by Charité – Universitätsmedizin Berlin CT images and tissue sections show how healthy, air-filled tissue is replaced by thickened, stiff connective tissue. Credit: Leitz/Charité Working alongside research groups from Heidelberg, researchers from Charité – Universitätsmedizin Berlin have elucidated the novel disease processes involved in the development of pulmonary fibrosis. They were able to show that...

Post

A lifeline for leaky lung cells

by Harvard University Leaky lungs are a very common side effect of heart failure, but all currently available drugs do is reduce the amount of fluid in the body, rather than plug the leak itself. A new gene therapy created at the Wyss Institute and Boston Children’s Hospital and tested in human Lung Chips blocks...

Post

Study shows surprising trends for a serious lung condition

Posted Today Pulmonary embolism is a potentially life-threatening condition, in which blood clots migrate to arteries in the lungs, with the risk for increased pressure on the right side of the heart, impaired breathing, and even death. Yale researchers recently studied trends in hospitalization and mortality rates for people with pulmonary embolism, and their findings...

Post

A new target for the treatment of idiopathic pulmonary fibrosis

by Experimental Biology and Medicine An article published in Experimental Biology and Medicine identifies a new target for the treatment of idiopathicpulmonary fibrosis. The study, led by Dr. Huaping Dai in the Department of Pulmonary and Critical Care Medicine and the Center of Respiratory Medicine at China-Japan Friendship Hospital and the National Clinical Research Center for Respiratory Disease in Beijing, China, reports that interleukin-25, an inflammatory...